Tempus AI Inc

TEM

Tempus AI Inc

@capurs
• 7 months ago

The business is growing

Is The Business Growing?

  1. "Our Q2 2025 revenues were $314.6 million, representing 89.6% year-over-year growth. Excluding legacy Ambry revenues, the core Tempus business grew 30.9%."

  2. "In the quarter, we ran ~84,000 NGS tests versus ~66,500 in Q2 2024, representing 26% growth (compared to 20% last quarter). Our Oncology revenue was $133.2 million in Q2 2025, representing 32.9% year-over-year growth, driven by increased volume and improvements in average selling price (ASP) on a year-over year-basis."

  3. Full Year 2024 Financial Highlights

    • Total Revenue: Increased to $693.4 million, representing 30.4% year-over-year growth.

    • Genomics Revenue: Was $451.7 million, representing 24.4% year-over-year growth, with unit growth of 23.8%.

    • Data and Services Revenue: Was $241.6 million, representing 43.2% year-over-year growth.

    • Gross Profit: Increased to $381.1 million, representing 33.2% growth year-over-year.